Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601)

BACKGROUND: Combination of S-1, an oral fluorouracil derivative, plus docetaxel against non-small cell lung cancer (NSCLC) showed promising efficacy but clinically problematic emesis. A phase I/II study utilising a new schedule for this combination was conducted. METHODS: A biweekly regimen of docet...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiyama, K, Kobayashi, K, Minezaki, S, Kotajima, F, Sutani, A, Kasai, T, Mori, K, Hoshi, E, Takayanagi, N, Koyama, S, Eguchi, K, Nakayama, M, Kikuchi, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493772/
https://www.ncbi.nlm.nih.gov/pubmed/23033004
http://dx.doi.org/10.1038/bjc.2012.437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493772/
https://www.ncbi.nlm.nih.gov/pubmed/23033004
http://dx.doi.org/10.1038/bjc.2012.437

Ejemplares similares